Literature DB >> 11425490

Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress.

T Heitzer1, B Finckh, S Albers, K Krohn, A Kohlschütter, T Meinertz.   

Abstract

The impairment of nitric oxide (NO)-mediated vasodilation in diabetes has been attributed to increased vascular oxidative stress. Lipoic acid has been shown to have substantial antioxidative properties. The aim of this study was to assess the effect of lipoic acid on NO-mediated vasodilation in diabetic patients in comparison with the well-recognized effect of ascorbic acid. Using venous occlusion plethysmography, we examined the effects of lipoic acid (0.2 mM) and ascorbic acid (1 and 10 mM) on forearm blood flow responses to acetylcholine, sodium nitroprusside and concomitant infusion of the NO-inhibitor, N(G)-monomethyl-L-arginine, in 39 diabetic patients and 11 control subjects. Plasma levels of antioxidants and parameters of lipid peroxidation were measured and correlated to endothelial function tests. Lipoic acid improved NO-mediated vasodilation in diabetic patients, but not in controls. NO-mediated vasodilation was improved by ascorbic acid at 10 mM, but not 1 mM. Improvements of endothelial function by ascorbic acid and lipoic acid were closely related. The beneficial effects of lipoic acid were positively related to plasma levels of malondialdehyde and inversely related to levels of ubiquinol-10. These findings support the concept that oxidative stress contributes to endothelial dysfunction and suggest a therapeutic potential of lipoic acid particularly in patients with imbalance between increased oxidative stress and depleted antioxidant defense.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425490     DOI: 10.1016/s0891-5849(01)00551-2

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  46 in total

Review 1.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  New insights into insulin action and resistance in the vasculature.

Authors:  Camila Manrique; Guido Lastra; James R Sowers
Journal:  Ann N Y Acad Sci       Date:  2014-03-20       Impact factor: 5.691

Review 3.  Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.

Authors:  Kate Petersen Shay; Régis F Moreau; Eric J Smith; Anthony R Smith; Tory M Hagen
Journal:  Biochim Biophys Acta       Date:  2009-08-04

Review 4.  Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

Authors:  Corey E Tabit; William B Chung; Naomi M Hamburg; Joseph A Vita
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

5.  The effect of alpha-lipoic acid (ALA) supplementation on cardiovascular risk factors in men with chronic spinal cord injury: a clinical trial.

Authors:  V Mohammadi; M Khalili; S Eghtesadi; S Dehghani; S Jazayeri; S K Aghababaee; H Sabour; H Saberi; M Eghtesadi; M R Gohari
Journal:  Spinal Cord       Date:  2015-03-10       Impact factor: 2.772

6.  Differential effects of tobacco cigarettes and electronic cigarettes on endothelial function in healthy young people.

Authors:  Kacey P Haptonstall; Yasmine Choroomi; Roya Moheimani; Kevin Nguyen; Elizabeth Tran; Karishma Lakhani; Isabella Ruedisueli; Jeffrey Gornbein; Holly R Middlekauff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-07-31       Impact factor: 4.733

7.  Alpha-lipoic acid does not acutely affect resistance and conduit artery function or oxidative stress in healthy men.

Authors:  James E Sharman; Prasad Gunaruwan; Wade L Knez; Matthias Schmitt; Susan A Marsh; Gary R Wilson; John R Cockcroft; Jeff S Coombes
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

8.  Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats.

Authors:  Hanke Mollnau; Matthias Oelze; Elena Zinßius; Michael Hausding; Zhixiong Wu; Maike Knorr; Jasmin Ghaemi Kerahrodi; Swenja Kröller-Schön; Thomas Jansen; Christine Teutsch; Carolyn Foster; Huige Li; Philip Wenzel; Eberhard Schulz; Thomas Münzel; Andreas Daiber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-02-27       Impact factor: 3.000

Review 9.  Vascular smooth muscle function in type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  David Montero; Guillaume Walther; Antonia Pérez-Martin; Nestor Vicente-Salar; Enrique Roche; Agnès Vinet
Journal:  Diabetologia       Date:  2013-07-18       Impact factor: 10.122

10.  Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus.

Authors:  Philip Wenzel; Andreas Daiber; Matthias Oelze; Moritz Brandt; Ellen Closs; Jian Xu; Thomas Thum; Johann Bauersachs; Georg Ertl; Ming-Hui Zou; Ulrich Förstermann; Thomas Münzel
Journal:  Atherosclerosis       Date:  2007-12-03       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.